[{"AccountsPayableCurrent_0_Q2_USD":4942000.0,"DerivativeGainLossOnDerivativeNet_2_Q2_USD":908000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":23048000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":6153000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-63778000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":10078000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":5723000.0,"ForeignCurrencyTransactionGainLossBeforeTax_2_Q2_USD":957000.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q2_USD":-3645000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":464000.0,"DerivativeLiabilitiesNoncurrent_0_Q2_USD":832000.0,"AccountsReceivableRelatedPartiesCurrent_0_Q2_USD":222000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":6621000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":223000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-1600000.0,"OtherExpenses_1_Q2_USD":500000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":316948000.0,"OtherAssetsCurrent_0_Q2_USD":1066000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":-70550000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":-42551000.0,"InvestmentIncomeInterest_2_Q2_USD":903000.0,"InvestmentIncomeInterest_1_Q2_USD":81000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":4647000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":-630000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-71180000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-37904000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_2_Q2_USD":1639000.0,"OtherExpenses_2_Q2_USD":839000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q2_USD":1535000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":-1332000.0,"LeaseCost_2_Q2_USD":2420000.0,"SubleaseIncome_2_Q2_USD":457000.0,"SubleaseIncome_1_Q2_USD":209000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q2_USD":69000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_2_Q2_USD":147000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_2_Q2_USD":14200000.0,"RestrictedCash_0_Q2_USD":2683000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_2_Q2_USD":3400000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":-630000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":4647000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.1133,"OperatingLeaseRightOfUseAsset_0_Q2_USD":26139000.0,"OperatingLeasePayments_2_Q2_USD":3155000.0,"LeaseCost_1_Q2_USD":1233000.0,"OperatingLeasePayments_1_Q2_USD":1731000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":5495000.0,"OperatingLeaseLiability_0_Q2_USD":35774000.0,"OperatingLeaseCost_2_Q2_USD":2579000.0,"OperatingLeaseCost_1_Q2_USD":1289000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":23296000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":2705000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":5490000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":5446000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":5544000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q2_USD":6040000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q2_USD":33845000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":59070000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":30279000.0,"VariableLeaseCost_1_Q2_USD":153000.0,"PaymentsToAcquireIntangibleAssets_2_Q2_USD":2214000.0,"Goodwill_0_Q2_USD":496000.0,"ProfitLoss_2_Q2_USD":-70550000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":3549000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":2392000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-62944000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-4606000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":3549000.0,"LiabilitiesNoncurrent_0_Q2_USD":89996000.0,"LiabilitiesCurrent_0_Q2_USD":29840000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":385341000.0,"Liabilities_0_Q2_USD":119836000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-981000.0,"ForeignCurrencyExchangeRateTranslation1_0_Q2_USD\/EUR":1.12,"PropertyPlantAndEquipmentNet_0_Q2_USD":29301000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.59,"CostsAndExpenses_2_Q2_USD":74997000.0,"CostsAndExpenses_1_Q2_USD":39912000.0,"CommonStockValue_0_Q2_USD":2692000.0,"CommonStockSharesOutstanding_0_Q2_shares":44444405.0,"CommonStockSharesIssued_0_Q2_shares":44444405.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":314265000.0,"AssetsNoncurrent_0_Q2_USD":65706000.0,"AssetsCurrent_0_Q2_USD":319635000.0,"Assets_0_Q2_USD":385341000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":11600123.0,"AdditionalPaidInCapital_0_Q2_USD":1000389000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-7319000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.96,"LongTermDebtNoncurrent_0_Q2_USD":35373000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-730257000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":44387463.0,"FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0_Q2_USD":800000.0,"PrepaidExpenseCurrent_0_Q2_USD":4082000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":2206000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":191000.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":7087000.0,"OtherIncome_2_Q2_USD":1526000.0,"OtherIncome_1_Q2_USD":669000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":31300000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_2_Q2_USD":3402000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":2470000.0,"ShareBasedCompensation_2_Q2_USD":10078000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":20583000.0,"StockholdersEquity_0_Q2_USD":265505000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":11511000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":28401000.0,"OperatingIncomeLoss_2_Q2_USD":-72671000.0,"OperatingIncomeLoss_1_Q2_USD":-38208000.0,"InterestPaidNet_2_Q2_USD":2545000.0,"InterestExpense_2_Q2_USD":1945000.0,"InterestExpense_1_Q2_USD":970000.0,"DepreciationAndAmortization_2_Q2_USD":3505000.0,"CommonStockSharesAuthorized_0_Q2_shares":60000000.0,"CommonStockParOrStatedValuePerShare_0_Q2_EUR":0.05,"CommitmentsAndContingencies_0_Q2_USD":null,"AccruedLiabilitiesCurrent_0_Q2_USD":13250000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":44333460.0,"ResearchAndDevelopmentExpense_2_Q2_USD":54414000.0,"VariableLeaseCost_2_Q2_USD":298000.0,"Ticker":"QURE","CIK":"1590560","name":"UNIQURE N.V.","OfficialName":"uniQure N.V. Ordinary Shares","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"814390930.0","Country":"Netherlands","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200730"}]